Tremelimumab AstraZeneca Európska únia - slovenčina - EMA (European Medicines Agency)

tremelimumab astrazeneca

astrazeneca ab - tremelimumab - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Imjudo Európska únia - slovenčina - EMA (European Medicines Agency)

imjudo

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - antineoplastické činidlá - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

CUMEL LATEXOVY Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cumel latexovy

artsana s.p.a. via saldarini catelli 1 22070 grandate (como) taliansko -